The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ABLE-22: Safety and efficacy evaluation of nadofaragene firadenovec alone or in combination with chemotherapy or immunotherapy—A randomized, open-label, phase 2 study.
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan; Bausch and Lomb; Bristol-Myers Squibb; CG Oncology; Ferring; Janssen Oncology; Johnson & Johnson; Olympus; pacific edge; Pfizer; Photocure; Protara Therapeutics; QED Therapeutics
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Stephen Boorjian
Consulting or Advisory Role - ArTara Therapeutics; Ferring; Janssen; Prokarium
 
Joshua Meeks
Honoraria - Astellas Pharma; AstraZeneca; ferring; Imvax; Janssen; Merck; Pfizer; Prokarium; Protara Therapeutics; Urogen pharma
Research Funding - Epizyme; Merck Sharp & Dohme
Patents, Royalties, Other Intellectual Property - NMIBC genetic classifier (Inst); TCGA Classifier (Inst)
Other Relationship - Olympus
 
Trinity Bivalacqua
Honoraria - Ferring; Janssen; UROGENE
 
Yair Lotan
Stock and Other Ownership Interests - C2i Genomics; CAPs Medical; Nanorobotics; Phinomics; Uroviu; Vessi Medical; Virtuoso Therapeutics
Consulting or Advisory Role - AbbVie; Ambu; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb; C2i Genomics; caps medical; Cleveland Diagnostics; Convergent Genomics; Fergene; Merck; Nanogen Biopharmaceutical; Nanorobotics; Nucleix; pacific edge; Phinomics; Photocure; Seagen; Stimit; UroGen pharma; uroviu; Verity Pharmaceuticals; Vessi Medical; Virtuoso Surgical; xCures
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); Storz (Inst)
 
Wassim Kassouf
Consulting or Advisory Role - AstraZeneca; BMS; Ferring; Janssen; Merck; Pfizer/EMD Serono; Photocure; Roche; Seagen
 
Girish Kulkarni
Honoraria - Abbvie; AstraZeneca Canada; Bayer; Knight Pharmaceuticals; Photocure; Tersera
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; enGene; Ferring; Janssen Oncology; Merck; Novartis; Pfizer; Theralase; Verity Pharmaceuticals
Research Funding - Johnson & Johnson/Janssen (Inst)
Travel, Accommodations, Expenses - Ferring
 
Paolo Gontero
No Relationships to Disclose
 
Peter Albers
Consulting or Advisory Role - Ferring
 
Joern Skibsted Jakobsen
Employment - Ferring
Stock and Other Ownership Interests - Ferring
 
Kristian Juul
Employment - Ferring
Stock and Other Ownership Interests - Ferring